The Effect of Subcutaneous and Intraperitoneal Anesthesia on Post Laparoscopic Pain
NCT ID: NCT05034406
Last Updated: 2021-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2019-05-01
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Levobupivacaine and Postoperative Pain Relief
NCT04869046
Lidocaine VS Hemodynamic, Metabolic and Hormonal Response
NCT05238506
Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Hernia Repair
NCT03041948
Posterior Quadratus Lumborum Block Using 0.125% Versus 0.25% Bupivacaine for Analgesia in Children Undergoing LPEC
NCT04998071
Postoperative Pain Relief in Children: Comparing Caudal Bupivacaine Alone Versus Bupivacaine With Dexmedetomidine for Infra-Umbilical Surgeries Under General Anesthesia
NCT07121764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lidocaine group
A total amount of 6 mL of 2% lidocaine was injected at the three trocar insertion sites (2 mL at each insertion site) prior to incision and 10 mL of 2% lidocaine was injected at the end of procedure, under the direct visualization of laparoscope, below and around the defect of the peritoneum at the site of varicocele.
2% Lidocaine
6 mL of 2% lidocaine injected at the trocar insertion site.
Levobupivacaine
Total amount of 6 mL of 0.5% levobupivacaine was injected at the three trocar insertion sites (2 mL at each) prior to incision and 10 mL of 2% lidocaine was injected at the end of procedure, under the direct visualization of laparoscope, below and around the defect of the peritoneum at the site of varicocele.
0.5% levobupivacaine
6 mL of 0.5% levobupivacaine injected at the trocar insertion site.
Control group
No local or peritoneal administration of any local anesthetic prior, during and after the surgical procedure
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2% Lidocaine
6 mL of 2% lidocaine injected at the trocar insertion site.
0.5% levobupivacaine
6 mL of 0.5% levobupivacaine injected at the trocar insertion site.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pediatric patients whose parents or guardians gave informed consent
Exclusion Criteria
* pediatric patients who underwent conversion to open procedure
* pediatric patients with chronic, metabolic and endocrine diseases
* pediatric patients with systemic infections
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KBC Split
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Goran Tintor
Medical doctor, surgery resident
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zenon Pogorelić, MD, PhD
Role: STUDY_CHAIR
University of Split, School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Split
Split, Split-Dalmatia County, Croatia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
500-03/20-01/09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.